glp-1 trump low-cost plan a likely boost for Eli Lilly, Novo Nordisk Weight-loss drug makers announce pricing
Description
Noom, Calibrate, and Embla say there is preliminary data to support their contention that many people can maintain weight loss through exercise and diet after stopping the medications (though some of the doctors Fortune spoke with were skeptical of those studies)
doi: 10.1212/wnl.0b013e3181ffe4f6
M.FriasJ
A: Often, yeswith medical oversight
Smaller companies are especially struggling
Boulton, C.D
